REGENERON PHARMACEUTICALS, INC. reports

Company location: Tarrytown, NY
Fiscal year end: 31 December

REGENERON PHARMACEUTICALS, INC. has filed 2,448 SEC EDGAR filings since 26 Jul 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 26-50 of 1,000 matching filings.

Per page

25

Current page

2

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2026
Reporting date: 02 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Jan 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Jan 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 31 Dec 2025
Reporting date: 30 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 11 Dec 2025
Reporting date: 09 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 11 Dec 2025
Reporting date: 09 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 11 Dec 2025
Reporting date: 09 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 11 Dec 2025
Reporting date: 09 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 11 Dec 2025
Reporting date: 09 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 24 Nov 2025
Reporting date: 20 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .